Interest of Eosinopia in the Diagnosis of Infection in the Emergency Department
NCT ID: NCT03467672
Last Updated: 2019-05-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2018-03-23
2020-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Main objective: Evaluation of the interest of eosinopenia in the diagnosis of bacterial infection in ED.
Methodology: inclusion of all patients with criteria for bacterial infection in ED, inclusion of an equivalent number of uninfected control patients.
Duration : 12 months Multicentric prospective study 6 centers : Strasbourg, Hôpital Nord Franche comté, Sélestat, Wissembourg, Colmar, Mulhouse
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Interest of Eosinopenia to Predict In-hospital Mortality Among Elderly Patients
NCT04734431
Link Between Eosinopenia and Bacterial Infections in the Elderly Subject Hospitalized in Geriatrics
NCT04363138
Characterize Novel Pathogen- and Host- Related Factors in Hospitalized Patients and Patients on the Emergency Department Presenting With Lower Respiratory Tract Infections and/or Sepsis
NCT02093247
Correlation Between Antibiotic Resistance and Incidence of Sepsis in Community Acquired Pneumonia
NCT05606627
How Routine Biomarkers and Blood Leucocytes Count Can Assist Diagnosis of COVID-19 in Emergency Department
NCT04401241
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infected patients
Diagnosis of bacterial infection
use of eosinopenia in the diagnosis of bacterial infection
Control group
Diagnosis of bacterial infection
use of eosinopenia in the diagnosis of bacterial infection
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnosis of bacterial infection
use of eosinopenia in the diagnosis of bacterial infection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patient suspected of infection and benefiting from the routine practice of NFS, whatever the indication during his / her visit to the emergency room.
* patient with or without criteria for bacterial infection
* patient affiliated to a social security scheme
* patient (or legal representative) who has agreed to participate in the study
Exclusion Criteria
* immunosuppressive treatment
* corticotherapy
* antibiotherapy in progress
* malignant hemopathy
* evolutionary cancer
* refusal to participate in the study
* subjects under safeguard of justice
* subject under guardianship or curatorship
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CH de COLMAR
Colmar, , France
CH de MULHOUSE
Mulhouse, , France
Ch Selestat
Sélestat, , France
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, , France
CH Nord Franche comte
Trévenans, , France
Ch Wissembourg
Wissembourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6228
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.